---
title: "Eli Lilly and Company's (LLY.US) Q4 2021 Earnings Conference Call"
description: "Eli Lilly and Company is engaged in the discovery, development, manufacture, and sale of pharmaceuticals. Its operations include human pharmaceuticals and anima"
locale: "en"
url: "https://longbridge.com/en/lives/7004"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Eli Lilly and Company's (LLY.US) Q4 2021 Earnings Conference Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Eli Lilly and Company is engaged in the discovery, development, manufacture, and sale of pharmaceuticals. Its operations include human pharmaceuticals and animal health products. The human pharmaceuticals division involves the discovery, development, manufacturing, marketing, and sale of global human pharmaceutical products in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular diseases, and others. The animal health products division operates through the Elanco Animal Health segment and is engaged in the development, production, and sale of food and companion animal products. Animal health products include ruminant products such as Somatuline, Tylan, Posilac, Paylean, as well as companion animal products such as Trifexis, Comfortis, and others. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, Indiana.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.